TIVC Tivic Health Systems, Inc.

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. The company's primary product, ClearUP, is a medical device intended to relieve sinus and nasal inflammation. It sells its products on direct-to-consumer channel through its own websites and platforms, such as Amazon.com, as well as to major U.S. online retailers, such as BestBuy.com, FSAStore.com, Walgreens.com, Walmart.com. The company was incorporated in 2016 and is headquartered in Newark, California.

$3.56
As of 11/30/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  11/11/2021
Outstanding shares:  8,881,181
Average volume:  1,931,065
Market cap:   $30,995,322
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -5.35
PS ratio:   20.89
Return on equity:   19.28%
Net income %:   -301.08%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy